{"id":"https://genegraph.clinicalgenome.org/r/4a0a169b-259d-465b-827e-33e8299271abv1.1","type":"EvidenceStrengthAssertion","dc:description":"DDX41-related hematologic malignancy predisposition syndrome is an autosomal-dominant (AD) condition characterized by incomplete penetrance, increased susceptibility to myeloid neoplasms and lymphoid malignancies. The DDX41 gene encodes a DEAD-box RNA helicase and is one of the 13 genes associated with autosomal dominant familial myeloid or lymphoid malignancies (PMID: 27133828, 28547672). DDX41 was first reported in relation to familial myeloid malignancy in a family with 4 family members affected by AML or MDS in 2015, where a germline frameshift variant in DDX41 was found to segregate in all tested affected individuals [PMID:25920683]. To date, at least 25 germline heterozygous variants (frameshift, splice, indel, missense) have been reported in over 70 families with a wide range of malignancies (PMID: 28547672, 28637623) of which 13 were included in this curation to maximize genetic evidence score (12 pts). The most commonly seen DDX41 variants are frameshifts, resulting in premature termination of the protein, suggesting loss of function or haploinsufficiency is the mechanism of tumorigenesis for this disorder (PMID:28637623, 26712909). This gene-disease association is also supported by rescue cell culture model, protein interactions, functional alteration and expression studies (PMID:25920683, 26944477). In summary, DDX41 is definitively associated with the autosomal-dominant (AD) DDX41-related hematologic malignancy predisposition syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/4a0a169b-259d-465b-827e-33e8299271ab","GCISnapshot":"https://genegraph.clinicalgenome.org/r/e3db8214-a39d-408d-a3c2-7b4e817b1cc1","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/e3db8214-a39d-408d-a3c2-7b4e817b1cc1_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-09-16T19:23:29.161Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/e3db8214-a39d-408d-a3c2-7b4e817b1cc1_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10023","date":"2020-07-30T20:29:35.621Z","role":"Approver"}],"curationReasonDescription":"","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e3db8214-a39d-408d-a3c2-7b4e817b1cc1_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e3db8214-a39d-408d-a3c2-7b4e817b1cc1_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/02c95116-fe7a-4593-bbb0-2b6c8c614abd_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","rdfs:label":"Family 31379","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/02c95116-fe7a-4593-bbb0-2b6c8c614abd","type":"Family","rdfs:label":"Family 31379","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/dafa94f0-0429-4911-bbde-3c050322ba79","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","rdfs:label":"III-1(family 31379)","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":56,"detectionMethod":"","firstTestingMethod":"Exome sequencing","phenotypes":"obo:HP_0002863","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/4ac891f1-e3e8-4088-b945-0c4a4ea3b931_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","allele":{"id":"https://genegraph.clinicalgenome.org/r/7573d2c7-e66c-4806-8d58-a0eb341af297","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016222.4(DDX41):c.1574G>A (p.Arg525His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358659"}}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0002863","obo:HP_0004808"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/dafa94f0-0429-4911-bbde-3c050322ba79"}},{"id":"https://genegraph.clinicalgenome.org/r/55d792cd-8b5f-4191-91e3-8e91c930c753_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","rdfs:label":"Family 20432","family":{"id":"https://genegraph.clinicalgenome.org/r/55d792cd-8b5f-4191-91e3-8e91c930c753","type":"Family","rdfs:label":"Family 20432","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/36808668-f55a-429f-a553-c9b23dcb9657","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","rdfs:label":"II-2 (Family 20432)","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":63,"detectionMethod":"","firstTestingMethod":"Exome sequencing","phenotypes":"obo:HP_0004808","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/3bccf64a-b970-4765-b65a-b0bc6b9954bb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","allele":{"id":"https://genegraph.clinicalgenome.org/r/a1312f32-95e5-4079-b14a-a2eed46500ed","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016222.4(DDX41):c.3G>A (p.Met1Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358661"}}}}},"phenotypeFreeText":"","phenotypePositiveAllelePositive":3,"phenotypes":"obo:HP_0004808","proband":{"id":"https://genegraph.clinicalgenome.org/r/36808668-f55a-429f-a553-c9b23dcb9657"}},{"id":"https://genegraph.clinicalgenome.org/r/1cc353ea-303f-4ea9-b71e-0e5b0d795df8_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","rdfs:label":"Family 33755","family":{"id":"https://genegraph.clinicalgenome.org/r/1cc353ea-303f-4ea9-b71e-0e5b0d795df8","type":"Family","rdfs:label":"Family 33755","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/7e1f4121-6001-48cd-be95-04bff633089c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","rdfs:label":"III-1 (family 33755)","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":54,"detectionMethod":"","firstTestingMethod":"Exome sequencing","phenotypes":"obo:HP_0004808","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/c5f9188c-8415-4250-8139-60d39a0ef7d3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","allele":{"id":"https://genegraph.clinicalgenome.org/r/7bd51f32-8d87-4d7b-ab9e-7981f952886c","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016222.4(DDX41):c.415_418dup (p.Asp140delinsGlyTer)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA280919"}}}}},"phenotypeFreeText":"","phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0002863","obo:HP_0004808"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/7e1f4121-6001-48cd-be95-04bff633089c"}},{"id":"https://genegraph.clinicalgenome.org/r/e777cb24-fd8c-48c4-bc15-10b59292b547_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","rdfs:label":"Family 154","family":{"id":"https://genegraph.clinicalgenome.org/r/e777cb24-fd8c-48c4-bc15-10b59292b547","type":"Family","rdfs:label":"Family 154","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/c9cfa37d-2fe9-49d7-a152-257b87d9d9ce","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","rdfs:label":"II-2 (Family 154)","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":67,"detectionMethod":"","firstTestingMethod":"Exome sequencing","phenotypes":"obo:HP_0002863","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d15e1c1d-40df-40b2-91bd-a53d388a8bbb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","allele":{"id":"https://genegraph.clinicalgenome.org/r/5d42c33e-6f6d-4ec4-89e8-007a6608e97a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016222.4(DDX41):c.435-2_435-1delinsCA","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA351429"}}}}},"phenotypeFreeText":"","phenotypePositiveAllelePositive":1,"phenotypes":"obo:HP_0002863","proband":{"id":"https://genegraph.clinicalgenome.org/r/c9cfa37d-2fe9-49d7-a152-257b87d9d9ce"}},{"id":"https://genegraph.clinicalgenome.org/r/8312664b-036d-4be6-8571-0a9ec460176a_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","rdfs:label":"Family 25476","estimatedLodScore":1.2,"family":{"id":"https://genegraph.clinicalgenome.org/r/8312664b-036d-4be6-8571-0a9ec460176a","type":"Family","rdfs:label":"Family 25476","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/6da41026-05d9-40f4-9e20-c203650db1c8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","rdfs:label":"III-6 (family  25476)","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":51,"detectionMethod":"","firstTestingMethod":"Exome sequencing","phenotypes":"obo:HP_0012189","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/696345aa-ccd2-42e1-827d-843f2f24a02c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","allele":{"id":"https://genegraph.clinicalgenome.org/r/85a5b217-1514-418c-aec4-034ed37065d0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016222.4(DDX41):c.490C>T (p.Arg164Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358665"}}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":5,"phenotypes":["obo:HP_0006775","obo:HP_0001909","obo:HP_0012189","obo:HP_0002665","obo:HP_0012539"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/6da41026-05d9-40f4-9e20-c203650db1c8"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}},{"id":"https://genegraph.clinicalgenome.org/r/d2fada15-ac51-44c4-bd6d-c5d67fc08f84_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920683","rdfs:label":"a second family","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/d2fada15-ac51-44c4-bd6d-c5d67fc08f84","type":"Family","rdfs:label":"a second family","ethnicity":{"id":"cg:UnknownEthnicity"},"member":{"id":"https://genegraph.clinicalgenome.org/r/39712c72-03bf-49c8-8f51-8aa89228b3aa","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920683","rdfs:label":"Case 4 (a second family)","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":64,"detectionMethod":"","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","phenotypes":"obo:HP_0002863","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/5d30f807-a79b-47df-a6ba-5e8afe3209d5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920683","allele":{"id":"https://genegraph.clinicalgenome.org/r/12b93643-85b3-4c24-8da0-a47f3b72bff1","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016222.4(DDX41):c.1187T>C (p.Ile396Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA358663"}}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0004808","obo:HP_0002863"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/39712c72-03bf-49c8-8f51-8aa89228b3aa"}},{"id":"https://genegraph.clinicalgenome.org/r/09575c73-2cc3-4797-90b7-666287d8bdc9_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920683","rdfs:label":"Family 6","family":{"id":"https://genegraph.clinicalgenome.org/r/09575c73-2cc3-4797-90b7-666287d8bdc9","type":"Family","rdfs:label":"Family 6","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/a7162ecb-81f2-4ec8-8ad0-9fd23a3df6ba","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920683","rdfs:label":"Case 10 (family 6)","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":62,"detectionMethod":"","phenotypes":"obo:HP_0002863","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/0e44def3-2c5d-4148-a0f5-918379af58fc_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920683","allele":{"id":"https://genegraph.clinicalgenome.org/r/7bd51f32-8d87-4d7b-ab9e-7981f952886c"}}}},"phenotypeFreeText":"","phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0004808","obo:HP_0002863"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/a7162ecb-81f2-4ec8-8ad0-9fd23a3df6ba"}},{"id":"https://genegraph.clinicalgenome.org/r/ef0d2757-1657-4a6d-a9a6-a3980e9b403b_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26944477","rdfs:label":"a Caucasian family","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/ef0d2757-1657-4a6d-a9a6-a3980e9b403b","type":"Family","rdfs:label":"a Caucasian family","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/3152f2dd-391a-4af7-8db4-2f5938774aef","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26944477","rdfs:label":"II-1 (From a Caucasian family)","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":67,"detectionMethod":"","firstTestingMethod":"Exome sequencing","phenotypes":"obo:HP_0004808","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/ee06d127-dcab-49b3-8993-2a2ba6a0eaa5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26944477","allele":{"id":"https://genegraph.clinicalgenome.org/r/11dad4aa-5ac2-4a8a-a600-05b1511d125d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016222.3:c.[711G>T;712C>A]","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/403734"}}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypePositiveAllelePositive":3,"phenotypes":["obo:HP_0004808","obo:HP_0002863"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/3152f2dd-391a-4af7-8db4-2f5938774aef"}},{"id":"https://genegraph.clinicalgenome.org/r/bf32ec03-239a-4e2b-9ca5-0604ee4d5257_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920683","rdfs:label":"the third family","family":{"id":"https://genegraph.clinicalgenome.org/r/bf32ec03-239a-4e2b-9ca5-0604ee4d5257","type":"Family","rdfs:label":"the third family","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/0240164d-0d5a-465d-a3c3-eb852aab5b9a","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920683","rdfs:label":"Case 6-a 67-year-old male (the third family)","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":67,"detectionMethod":"","firstTestingMethod":"Exome sequencing","phenotypes":"obo:HP_0002863","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/42b2b5ef-d74a-4d7d-a087-00f4cd06f32a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920683","allele":{"id":"https://genegraph.clinicalgenome.org/r/7bd51f32-8d87-4d7b-ab9e-7981f952886c"}}}},"phenotypeFreeText":"","phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0002863","obo:HP_0004808"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/0240164d-0d5a-465d-a3c3-eb852aab5b9a"}},{"id":"https://genegraph.clinicalgenome.org/r/3c4320dc-ccd6-4c26-943a-d392c5898ce9_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28194039","rdfs:label":"Family of a 49-year-old man","family":{"id":"https://genegraph.clinicalgenome.org/r/3c4320dc-ccd6-4c26-943a-d392c5898ce9","type":"Family","rdfs:label":"Family of a 49-year-old man","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/deba3be3-b8d2-4c8e-b2a0-fd06b332fedd","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28194039","rdfs:label":"A 49-year-old man","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":49,"detectionMethod":"","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002863","obo:HP_0004808"],"previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/a3270241-2cc1-4af9-9d24-32849b9adca5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/28194039","allele":{"id":"https://genegraph.clinicalgenome.org/r/f58ed88b-d481-419f-98aa-5c42164b765d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_016222.4(DDX41):c.1496dup (p.Ala500CysfsTer9)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA3584730"}}}}},"phenotypeFreeText":"","phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0004808","obo:HP_0002863"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/deba3be3-b8d2-4c8e-b2a0-fd06b332fedd"}},{"id":"https://genegraph.clinicalgenome.org/r/5b09cbee-92d2-4e2a-ae5a-1244dca136b8_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","rdfs:label":"Family 277","family":{"id":"https://genegraph.clinicalgenome.org/r/5b09cbee-92d2-4e2a-ae5a-1244dca136b8","type":"Family","rdfs:label":"Family 277","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/3e2f371e-b867-4cad-8e03-79cdf275db33","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","rdfs:label":"II-1 (From family 277)","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":73,"detectionMethod":"","firstTestingMethod":"Exome sequencing","phenotypes":"obo:HP_0004808","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/d843cd82-b59d-4b8e-be16-3a3e5e912a0c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","allele":{"id":"https://genegraph.clinicalgenome.org/r/7bd51f32-8d87-4d7b-ab9e-7981f952886c"}}}},"phenotypeFreeText":"","phenotypePositiveAllelePositive":1,"phenotypes":["obo:HP_0002863","obo:HP_0004808"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/3e2f371e-b867-4cad-8e03-79cdf275db33"}},{"id":"https://genegraph.clinicalgenome.org/r/712dc49c-f72b-4edb-b703-3ad438f14722_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","rdfs:label":"Family 235","family":{"id":"https://genegraph.clinicalgenome.org/r/712dc49c-f72b-4edb-b703-3ad438f14722","type":"Family","rdfs:label":"Family 235","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/22a9705c-9e5a-4eb4-b5e7-ffde113be618","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","rdfs:label":"II-2 (family 235)","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":69,"detectionMethod":"","firstTestingMethod":"Exome sequencing","phenotypes":"obo:HP_0004808","previousTesting":false,"previousTestingDescription":"","sex":"Female","variant":{"id":"https://genegraph.clinicalgenome.org/r/9b19f54a-6742-4dc2-a553-af325f88c809_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26712909","allele":{"id":"https://genegraph.clinicalgenome.org/r/7bd51f32-8d87-4d7b-ab9e-7981f952886c"}}}},"phenotypeFreeText":"","phenotypePositiveAllelePositive":1,"phenotypes":"obo:HP_0004808","proband":{"id":"https://genegraph.clinicalgenome.org/r/22a9705c-9e5a-4eb4-b5e7-ffde113be618"}},{"id":"https://genegraph.clinicalgenome.org/r/ee2f2b5b-d085-4ca5-8803-21f0b4697b93_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920683","rdfs:label":"another leukemia family","estimatedLodScore":0.6,"family":{"id":"https://genegraph.clinicalgenome.org/r/ee2f2b5b-d085-4ca5-8803-21f0b4697b93","type":"Family","rdfs:label":"another leukemia family","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/84d6c760-a0db-4d98-8f97-82723b4ae6ee","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920683","rdfs:label":"Case 7-a 73-year-old male patient","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":73,"detectionMethod":"","firstTestingMethod":"Exome sequencing","phenotypes":"obo:HP_0004808","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/62282875-5959-469b-bf35-636d3676ad59_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920683","allele":{"id":"https://genegraph.clinicalgenome.org/r/7bd51f32-8d87-4d7b-ab9e-7981f952886c"}}}},"meetsInclusionCriteria":false,"phenotypeFreeText":"","phenotypePositiveAllelePositive":2,"phenotypes":"obo:HP_0004808","proband":{"id":"https://genegraph.clinicalgenome.org/r/84d6c760-a0db-4d98-8f97-82723b4ae6ee"}},{"id":"https://genegraph.clinicalgenome.org/r/2b91af23-081e-43ab-b1b9-ffa69960e3a3_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920683","rdfs:label":"the index family","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/2b91af23-081e-43ab-b1b9-ffa69960e3a3","type":"Family","rdfs:label":"the index family","ethnicity":{"id":"https://genegraph.clinicalgenome.org/r/"},"member":{"id":"https://genegraph.clinicalgenome.org/r/3eeb050b-1cda-4e86-a7f8-7fdbfa9f03b8","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920683","rdfs:label":"Case 3-the son (the index family)","ageType":"AgeAtDiagnosis","ageUnit":"Years","ageValue":45,"detectionMethod":"whole exome sequencing (WES),","ethnicity":{"id":"cg:UnknownEthnicity"},"firstTestingMethod":"Exome sequencing","phenotypes":"obo:HP_0004808","previousTesting":false,"previousTestingDescription":"","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/38394e3c-1005-4ef2-9784-95e01f7a098b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920683","allele":{"id":"https://genegraph.clinicalgenome.org/r/7bd51f32-8d87-4d7b-ab9e-7981f952886c"}}}},"meetsInclusionCriteria":true,"phenotypeFreeText":"","phenotypePositiveAllelePositive":4,"phenotypes":"obo:HP_0004808","proband":{"id":"https://genegraph.clinicalgenome.org/r/3eeb050b-1cda-4e86-a7f8-7fdbfa9f03b8"},"sequencingMethod":{"id":"cg:AllGenesSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e3db8214-a39d-408d-a3c2-7b4e817b1cc1_ad_other_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4ac891f1-e3e8-4088-b945-0c4a4ea3b931_proband_score_evidence_line","type":"EvidenceLine","dc:description":"This family features high penetrance MDS/AML, in which nine family members were diagnosed with AML, MDS or leukemia, and three of them were tested and showed germline variant DDX41c.1574G>A (p.R525H). Two other phenotypically normal family members were tested and did not show this variant.  The p.R525H variant has been shown to affect the interaction of DDX41 with splicing factors (PMID: 25920683). The functional data, together with the recurrence and segregation with the disease of this variant in this family support that the p.R525H variant in DDX41 is causative for this disease syndrome.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dafa94f0-0429-4911-bbde-3c050322ba79"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/696345aa-ccd2-42e1-827d-843f2f24a02c_proband_score_evidence_line","type":"EvidenceLine","dc:description":"4 of 4 affected individuals with NHL, Hodgkin lymphoma, or multiple myeloma carried the p.R164W variant, whereas 3 of 3 unaffected individuals of similar ages did not. Arginine 164 is highly conserved across species and is adjacent to the Q motif, a region involved in adenosine triphosphate binding and hydrolysis, likely key for regulating DDX41 helicase activity.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6da41026-05d9-40f4-9e20-c203650db1c8"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5d30f807-a79b-47df-a6ba-5e8afe3209d5_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The identical twin brothers developed MDS, and AML was observed in their father. Both twins showed a germline variant DDX41c.1187T>C (p.I396T) and the somatic variant DDX41c.1574G>A (p.R525H) which was confirmed as present in trans, relative to the germline lesion (Fig S2F)","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/39712c72-03bf-49c8-8f51-8aa89228b3aa"}],"specifiedBy":"GeneValidityProbandADNonNullCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantOtherVariantEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e3db8214-a39d-408d-a3c2-7b4e817b1cc1_ad_null_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/62282875-5959-469b-bf35-636d3676ad59_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The 73-year-old male proband was diagnosed with secondary AML, whereas his nephew presented with AML at the age of 56. Both patients harbored the same germline frameshift variant c.415_418dup (p.Asp140delinsGlyTer).  Paternal cousins of the index case were also affected by AML at the ages of 79 and 89, but they declined genetic testing.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/84d6c760-a0db-4d98-8f97-82723b4ae6ee"}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/c5f9188c-8415-4250-8139-60d39a0ef7d3_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The proband harbored a somatic variant DDX41c.1574G>A (p.R525H)","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7e1f4121-6001-48cd-be95-04bff633089c"}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3bccf64a-b970-4765-b65a-b0bc6b9954bb_proband_score_evidence_line","type":"EvidenceLine","dc:description":"DDX41 c.3G>A (p.M1I) is a start-loss variant and was reported in another family (family 236) in the same paper as well. The recurrence and segregation with the disease in both families support that the variant M1I is causative for this disease syndrome.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/36808668-f55a-429f-a553-c9b23dcb9657"}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/38394e3c-1005-4ef2-9784-95e01f7a098b_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The variant DDX41 c.415_418dup (p.Asp140delinsGlyTer) was reported in this literature as DDX41 c.419insGATG (p.D140fs) due to the use of alternate nomenclature. It is the most frequent DDX41 germline variant associated with MPLPF, and it causes a premature stop codon[ PMID:25920683, PMID:26712909]. The proband and his father also have the somatic variant DDX41 c.1574G>A (p.R525H).","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3eeb050b-1cda-4e86-a7f8-7fdbfa9f03b8"}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/d843cd82-b59d-4b8e-be16-3a3e5e912a0c_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3e2f371e-b867-4cad-8e03-79cdf275db33"}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/ee06d127-dcab-49b3-8993-2a2ba6a0eaa5_proband_score_evidence_line","type":"EvidenceLine","dc:description":"Expression study showed that expression of mutant DDX41-GFP was absent or barely detectable in the vast majority of transfected cells, suggesting the variant results in a loss of function. The proband showed somatic variant DDX41 c.1574G>A (p.R525H), which is the most frequently identified variant in DDX41 associated MDS/AML syndrome.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/3152f2dd-391a-4af7-8db4-2f5938774aef"}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/d15e1c1d-40df-40b2-91bd-a53d388a8bbb_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The variant DDX41 c.435-2_435-1delinsCA is classified as c.435-2_435-1delinsCA on ClinVar. Analysis of patient cells showed the presence of aberrant mRNA species that were predicted to result in frameshifts and prematurely terminated proteins. There was evidence of incomplete penetrance in this family since the proband's two sisters were carriers, but not affected at age of 65 and 75 years seperately.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c9cfa37d-2fe9-49d7-a152-257b87d9d9ce"}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/9b19f54a-6742-4dc2-a553-af325f88c809_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/22a9705c-9e5a-4eb4-b5e7-ffde113be618"}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/42b2b5ef-d74a-4d7d-a087-00f4cd06f32a_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The proband harbored both a germline variant DDX41 c.415_418dup (p.Asp140delinsGlyTer) and the somatic variant DDX41 c.1574G>A (p.R525H). His brother also died from AML at the age of 58 years.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0240164d-0d5a-465d-a3c3-eb852aab5b9a"}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a3270241-2cc1-4af9-9d24-32849b9adca5_proband_score_evidence_line","type":"EvidenceLine","dc:description":"The variant A500CfsTer9 was reported as F498fs* in this paper.\nThe proband underwent myeloablative allogenic BM transplantation (BMT) from his HLA-identical brother after a diagnosis with MDS and then developed AML seventeen month later. Short tandem repeat analysis demonstrated that donor cell leukemia (DCL) had developed from the allogenic BM of the sibling. The DDX41germline variant A500CfsTer9 was identified in both the donor and the patient.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/deba3be3-b8d2-4c8e-b2a0-fd06b332fedd"}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/0e44def3-2c5d-4148-a0f5-918379af58fc_proband_score_evidence_line","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a7162ecb-81f2-4ec8-8ad0-9fd23a3df6ba"}],"specifiedBy":"GeneValidityProbandADNullCriteria","strengthScore":1.5}],"specifiedBy":"GeneValidityOverallAutosomalDominantNullVariantEvidenceCriteria","strengthScore":10}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/e3db8214-a39d-408d-a3c2-7b4e817b1cc1_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e3db8214-a39d-408d-a3c2-7b4e817b1cc1_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a934fbc2-3fdf-415d-98a9-a89194d309ad","type":"EvidenceLine","dc:description":"Western blotting of native protein in primary extract as well as immunoprecipitates obtained with anti-DDX41 confirmed the findings of the mass spectrometry experiments (Figure S6C). Of note, variants in DDX41 (R525H) altered the native DDX41 interactome especially for major components in U2 (SF3B1, SF3B2, and SF3B3) and U5 (PRPF8 and SNRNP200) spliceosomes (Figure 5B). Western blots performed for SF3B1 and PRPF8 (Figure S6D) confirmed the differences between mutant and WT DDX41 immunoprecipitates. Increase points because this protein interaction is supported by different analysis approaches including mass spectrometry, Western blotting and altered interactions in variant (R525H).","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7197ae4a-524d-4c8b-bd18-7263bc6724cc","type":"Finding","dc:description":"Spliceosomal proteins are commonly involved in myeloid neoplasms (PMID: 22594801)\nAn epitope-tagged version of WT DDX41 was expressed in HEK293 cells and a mass spectrometry analysis of proteins associated with DDX41 was performed in an antibody pull-down followed by peptide sequencing. PRPF8 and SF3B1 are exemplary spliceosomal proteins found in a complex with DDX41.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920683","rdfs:label":"Immunoprecipitation and mass spectrometry analysis","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e3db8214-a39d-408d-a3c2-7b4e817b1cc1_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5793aa3b-5c09-44c7-89b7-c7c31f87b447","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/63d65c50-0eaa-41dc-ba67-f838071157c1","type":"FunctionalAlteration","dc:description":"Approximately 30%-40% of transfected cells expressed WT DDX41-GFP protein, which localized to the nucleus. Conversely, expression of mutant DDX41-GFP was absent or barely detectable in the vast majority of transfected cells. In cells that did express mutant DDX41-GFP, localization was predominately nuclear, though partial cytoplasmic expression was evident in some cells, indicating a possible defect in nuclear localization. Western blot corroborated these results, revealed absent mutant DDX41-GFP expression in transfected cells, suggesting the variant results in a loss of function.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/26944477","rdfs:label":"Expression of WT and mutant forms of DDX41"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/9fe3307b-9f04-4fdb-b296-28a90a800a07","type":"EvidenceLine","dc:description":"Similarly, CD34+ hematopoietic progenitor cells transduced with shRNA against DDX41 showed significantly enhanced colony formation (Figure 4C).This functional alteration is further supported by serial replating assays. CD34+ cells with knockdown of DDX41 and thus decreased levels of DDX41 resulted in a higher sensitivity to growth factor stimuli compared to control (Figures 4D and 4E), suggesting that loss of DDX41 expression is associated with enhanced proliferative capacity in myeloid neoplasms.","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/474abc40-e76e-4b69-be08-56bb7cc5efdc","type":"FunctionalAlteration","dc:description":"To model consequences of DDX41 deficiency, lentiviral shRNA delivery was employed to knock down DDX41 in K562 cells. Enhanced proliferation was observed in DDX41 knock down cells compared to mock transduced cells.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920683","rdfs:label":"knock down of DDX41"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/fb795651-ea92-4b41-ab55-c6b8fca38c95","type":"EvidenceLine","dc:description":"The enhanced skipping of this exon was recapitulated by DDX41 knockdown in K562 and CD34+ cells. In contrast, overexpression of WT DDX41 in U937 cells led to decreased exon skipping of ZMYM2 in comparison to mock transduction (Figure 6D; Figures S7B and S7C).","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4dae29f-0008-4b24-90ba-4702952abe33","type":"FunctionalAlteration","dc:description":"DDX41 defects were associated with more avid exon skipping (excess of shorter mRNA missing an exon) and more exon retention (excess of longer mRNA incor- porating an exon), including exon skipping in the ZMYM2 gene.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920683","rdfs:label":"Deep whole RNA sequencing"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e3db8214-a39d-408d-a3c2-7b4e817b1cc1_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/859af818-db85-4b3d-bc9d-ae71e027c79e","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/28a54952-3510-4b94-b369-8947b8d98640","type":"Finding","dc:description":"Forced expression of DDX41 in these DDX41-defective primary cells reduced colony formation, suggesting that loss of DDX41 expression is associated with enhanced prolifer- ative capacity in myeloid neoplasms.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920683","rdfs:label":"Forced expression of DDX41 in del(5q) primary sAML cells","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/af8a839a-0b10-4512-9ee1-9a08186ff918","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/729e1c29-260b-4226-9939-3e78e64e57fe","type":"Finding","dc:description":"DDX41 knockdown in K562 cells slightly impaired apigetrin-induced erythroid differentiation (Figures 4H, 4I, S5E, and S5F). As a rescue experiment, flow cytometry analysis showed higher expression of the CD11b and CD14 differentiation marker in U937 cells with forced expression of DDX41 (Figure S5G). In addition, up-modulation of DDX41 reversed the relative apoptotic resistance of U937 cells (Figure S5G).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25920683","rdfs:label":"Flow cytometry analysis","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityCellCultureRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5}],"evidenceStrength":"Definitive","sequence":1045,"specifiedBy":"GeneValidityCriteria7","strengthScore":17,"subject":{"id":"https://genegraph.clinicalgenome.org/r/ckWp4-fVIZE","type":"GeneValidityProposition","disease":"obo:MONDO_0014809","gene":"hgnc:18674","modeOfInheritance":"obo:HP_0000006"},"version":"1.1","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_e3db8214-a39d-408d-a3c2-7b4e817b1cc1-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}